--- title: "SLRX.US (SLRX.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/SLRX.US/news.md" symbol: "SLRX.US" name: "SLRX.US" parent: "https://longbridge.com/en/quote/SLRX.US.md" datetime: "2026-05-21T16:52:37.013Z" locales: - [en](https://longbridge.com/en/quote/SLRX.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/SLRX.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/SLRX.US/news.md) --- # SLRX.US (SLRX.US) — Related News ### [13:00 ETArna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform](https://longbridge.com/en/news/277080888.md) *2026-02-26T18:02:17.000Z* > Arna Pharma Inc. and Slate Run Pharmaceuticals have signed a Memorandum of Understanding (MOU) to establish a joint vent ### [Slate Medicines raises $130m in funds to progress anti-PACAP treatments](https://longbridge.com/en/news/276876652.md) *2026-02-25T11:15:52.000Z* > Slate Medicines has raised $130 million in a Series A financing round to advance its anti-PACAP migraine therapies, spec ### [Salus Scientific vows to maintain quality and safety standards despite industry recalls. - Company: Salus Scientific- Location: Charleston, S.C- Date: Feb. 24, 2026- Focus: Superior quality and safety- Key Message: Reaffirming commitment to top-tier radiation protection materials.](https://longbridge.com/en/news/276772395.md) *2026-02-24T17:34:29.000Z* > In Charlestown, South Carolina on February 24, 2026, Salus Scientific, known as the Occupational Wellness Company, respo ### [Salarius Pharmaceuticals becomes Decoy Therapeutics with Nasdaq ticker DCOY, emphasizing peptide conjugate therapeutics.](https://longbridge.com/en/news/272569856.md) *2026-01-14T14:20:30.000Z* > Salarius Pharmaceuticals has rebranded as Decoy Therapeutics, now trading under the Nasdaq ticker DCOY. The company is f ### ["Salarius Pharmaceuticals rebrands as Decoy Therapeutics, with Nasdaq ticker symbol DCOY, highlighting peptide conjugate focus."](https://longbridge.com/en/news/272103841.md) *2026-01-09T16:25:05.000Z* > Salarius Pharmaceuticals has rebranded as Decoy Therapeutics, adopting the Nasdaq ticker symbol DCOY, to emphasize its f ### [U.S. stock market movement update: SMX surged 85%, Bristol-Myers rose 63%, Cohen fell 30%, and short-term capital in the market is active](https://longbridge.com/en/news/271832630.md) *2026-01-07T20:00:09.000Z* > Overview of the US Stock Market Recently, the US stock market has shown strong sector rotation, with the technology and ### [Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics | SLRX Stock News](https://longbridge.com/en/news/271799112.md) *2026-01-07T05:45:00.000Z* > Salarius Pharmaceuticals, Inc. will change its name to Decoy Therapeutics Inc. and its Nasdaq ticker symbol to DCOY, eff